Rheumatology Evidence Update January 2024

*|MC_PREVIEW_TEXT|*

Rheumatology Evidence Update 30th January 2024 Contents Leicester Publications Cochrane Systematic Reviews NICE Guidance Other items of interest COVID-19 Updates East Midlands Evidence Repository NIHR Signals UpToDate   This Evidence Update is useful to me Request an evidence search Leicester Publications If your paper doesn't feature here, please let me know!   Clinicians' Interpretation of Unreported Chest Radiographs in Biologic Prescription Workup Service: A Comprehensive Analysis. Farman F, Mohammed Murad A, Sunmboye KO. Chest X-ray Reporting: A Comparative Study of Specialist Nurses and Trainee Doctors' Knowledge in the Biologic Prescription Service. Mohammed Murad A, Farman F, Sunmboye KO. Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population. Sunmboye K, Petrie T, Durrani M. Utilizing Clinical and Non-clinical Patient Factors in Predicting Cardiovascular Events in Patients on JAK Inhibitor Therapy: A Retrospective Cohort Study. Sunmboye KO, Petrie T, Bui B, Salim H, Khan M. Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. Quick V, Abusalameh M, Ahmed S, Alkoky H, Bukhari M, Carter S, Coath FL, Davidson B, Doddamani P, Dubey S, Ducker G, Griffiths B, Gullick N, Heaney J, Holloway A, Htut EEP, Hughes M, Irvine H, Kinder A, Kurshid A, Lim J, Ludwig DR, Malik M, Mercer L, Mulhearn B, Nair JR, Patel R, Robson J, Saha P, Tansley S; TOC STOP 2022 Investigators; Mackie SL. Pericarditis of Polyarteritis Nodosa. Ambrogetti R, Taha O, Awan B, Memon A, Sunmboye KO. Does patient-reported bath ankylosing spondylitis disease activity index correlate with inflammatory back pain and extra-articular manifestations in axial spondyloarthropathy? Patel R, Byravan S, Moorthy A.   For up-to-date publications from UHL, click here. Decision aids for people facing health treatment or screening decisions     For up to date Cochrane Reviews click here. Transition from children's to adults' services   Other noteworthy research Please let me know what sorts of things you'd like to see here. Systematic Reviews   |   RCTs   |   Clinical Trials   |   Qualitative   |   Other Systematic Reviews Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome. Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Clinical prediction models for knee pain in patients with knee osteoarthritis: a systematic review. The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis. Sex Bias in Diagnostic Delay: Are Axial Spondyloarthritis and Ankylosing Spondylitis Still Phantom Diseases in Women? A Systematic Review and Meta-Analysis. Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis. Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis. Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41. Is it possible to predict which patients are most likely to benefit from intra-articular corticosteroid injections? A systematic review. Occurrence of bisphosphonate-associated osteonecrosis of the jaws in individuals with rheumatoid arthritis - a systematic review. CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis. Effectiveness and cost-effectiveness of telerehabilitation for musculoskeletal disorders: A systematic review and meta-analysis. The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies. Randomised Controlled Trials Influence of the intelligent knee osteoarthritis lifestyle app (iKOALA) on knee joint pain. Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial. Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial. Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study. Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial. Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial. The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial. Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial. Effectiveness of functional training versus resistance exercise in patients with psoriatic arthritis: randomized controlled trial. Comparison of telerehabilitation methods for patients with systemic sclerosis in the COVID-19 Era: A randomized controlled study. Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial. Clinical Trials A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity. Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis. The effects of Pilates training on respiratory muscle strength in patients with ankylosing spondylitis. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Personalised care packages for people with rheumatoid arthritis: a mixed-methods study. Qualitative Studies Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography. Healthcare professionals' perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review. The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus. A qualitative study of pain and related symptoms experienced by people with Ehlers-Danlos syndromes. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment. A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients. Other The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate.   COVID-19 Updates Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study. COVID-19 infection characteristics, risk factors and its potential impacts on Takayasu arteritis: a web-based survey in a large cohort. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial. The impact of COVID-19 on rheumatology health-care workers and their scientific output: heavy lies the crown on women in rheumatology. Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY. Latest articles on COVID-19 from PubMed - sorted by date added to PubMed EMER - the East Midlands Evidence Repository The East Midlands Evidence Repository (EMER) is the official institutional research repository for; Derbyshire Community Health Services, Leicester Partnership Trust, NHS Nottingham and Nottinghamshire CCG, Nottinghamshire Healthcare, Sherwood Forest Hospitals, University Hospitals of Derby and Burton and the University Hospitals Of Leicester EMER is intended to make NHS research more visible and discoverable by capturing, storing and preserving the East Midlands research output and making it available to the research community through open access protocols. Wherever possible, full-text content is provided for all research publications in the repository. Content grows daily as new collections are added. https://eastmid.openrepository.com/ NIHR Signals Tool could reduce blood test monitoring for most people on methotrexate New biological treatments for lupus do not increase the risk of serious infections   https://evidence.nihr.ac.uk/alerts/ https://www.uptodate.com/contents/whats-new-in-rheumatology  https://www.dynamed.com/browse/rheumatology British Society for Rheumatology https://www.rheumatology.org.uk/news-policy If you like these emails, but would love even more tailored alerts on your personal research interests, then consider signing up for KnowledgeShare, our new current awareness alerting service here: http://www.uhl-library.nhs.uk/knowledgeshare Request an evidence search To access full text you may have to log in to your NHS Athens account (click here to register for free).  If full text is not available then please email us to request a copy. This Evidence Update is NOT useful to me This Evidence Update is useful to me   View our other Evidence Updates Our mailing address is: pip.divall@uhl-tr.nhs.uk Attribution-NonCommercial-NoDerivs  CC BY-NC-ND   Copyright © 2016 UHL Clinical Librarian Service Share Tweet Forward

This email was sent to *|EMAIL|* why did I get this?    unsubscribe from this list    update subscription preferences *|LIST:ADDRESSLINE|* *|REWARDS|*